Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-12-024891
Filing Date
2012-04-19
Accepted
2012-04-19 18:36:56
Documents
1
Period of Report
2011-05-14

Document Format Files

Seq Description Document Type Size
1 rrd342154.html 4  
1 rrd342154.xml 4 8145
  Complete submission text file 0001181431-12-024891.txt   9688
Mailing Address C/O SAGENT PHARMACEUTICALS, INC. 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address
FLANAGAN ROBERT J (Reporting) CIK: 0001251512 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35144 | Film No.: 12769265

Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195
Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604
Sagent Pharmaceuticals, Inc. (Issuer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
SIC: 2834 Pharmaceutical Preparations